Related Experiment Video
Updated: Jul 1, 2025

07:38
Strategies for Assessing Autistic-Like Behaviors in Mice
Published on: September 20, 2024
966
Exploratory Analysis of MicroRNA Alterations in a Neurodevelopmental Mouse Model for Autism Spectrum Disorder and
Susana García-Cerro1,2, Ana Gómez-Garrido1,2, Gonçalo Garcia3,4
1Translational Psychiatry Group, Ibis-Biomedicine Institute of Sevilla-CSIC, Manuel Siurot AV, 41013 Seville, Spain.
International Journal of Molecular Sciences
|March 13, 2024
Summary
This study investigated microRNAs (miRNAs) in a mouse model of autism spectrum disorder (ASD) and schizophrenia (SCZ). Key miRNAs showed altered expression, with some differing between sexes, suggesting potential biomarkers for these neurodevelopmental disorders.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- MicroRNAs (miRNAs) are critical regulators of gene expression implicated in autism spectrum disorder (ASD) and schizophrenia (SCZ).
- Understanding miRNA dysregulation in neurodevelopmental disorders is crucial for identifying pathological mechanisms and therapeutic targets.
Purpose of the Study:
- To investigate the expression profiles of specific miRNAs in the prefrontal cortex (PFC) of a neurodevelopmental mouse model mimicking perinatal pathology relevant to ASD and SCZ.
- To examine potential sexual dimorphism in miRNA expression within this model.
- To identify miRNAs that could serve as biomarkers or therapeutic targets for ASD and SCZ.
Main Methods:
- Utilized a mouse model induced by ketamine administration during early postnatal development to mimic neuropathogenesis of ASD and SCZ.
- Analyzed adult prefrontal cortex miRNA expression, focusing on those previously linked to ASD (miR-451a, miR-486-3p) and SCZ (miR-132-3p, miR-137-3p), as well as those implicated in both.
- Investigated sex-specific differences in miRNA expression patterns.
Main Results:
- Observed significant alterations in PFC miRNA expression in the ASD- and SCZ-like mouse model.
- Identified upregulation of miR-451a and downregulation of miR-137-3p.
- Detected sexual dimorphism in the expression of miR-132-3p, miR-137-3p, and miR-92a-2-5p.
Conclusions:
- The findings highlight the altered expression of specific miRNAs in a mouse model relevant to ASD and SCZ.
- Sexual dimorphism in miRNA expression suggests distinct pathological pathways or responses in males and females.
- miR-92a-2-5p, miR-132-3p, miR-137-3p, and miR-451a are proposed as potential biomarkers and therapeutic targets for ASD and SCZ.

